Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: David Culver who wrote (113)	3/9/2000 7:27:00 PM
From: Heat Shock	Read Replies (1) \| Respond to of 236

To all: the Excited States receives StressGen's attention: Daniel Korpolinski appointed President and CEO of StressGen's U.S. operations - Appointment will accelerate plans for US market presence - newswire.ca From the PR: This is the first step in the company's strategy toward moving into the US financial market and fortifying the company's management as it enters a more mature stage of development. The appointment of Mr. Korpolinski will help the company achieve a number of key objectives. These include the creation of corporate alliances with major pharmaceutical companies, an enhanced presence in the US pharmaceutical and financial community and a plan to seek a listing on a US exchange. StressGen's present CEO, Richard Glickman- a brilliant young guy, will move to vice-chairman of the board. Glickman served the company well in its formative years. The new CEO will likely spend time in StressGen's new U.S. office, which was opened last April. It's in Collegeville, PA, just outside of Philadelphia. Heat.